BONNIE HUGHES: Open Payments
NPI 1760100531 · MCCOMB, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,707 in 127 payments from 18 companies in 2025. Trend: 2023 $1,476 · 2024 $1,693 · 2025 $2,707
Food & beverage: $2,631Education: $77
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 44 | $664 |
| Janssen Biotech, Inc. | 26 | $584 |
| Madrigal Pharmaceuticals | 9 | $402 |
| Ardelyx, Inc. | 9 | $177 |
| Regeneron Healthcare Solutions, Inc. | 6 | $176 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $100 |
| QOL Medical, LLC | 4 | $100 |
| Phathom Pharmaceuticals, Inc. | 4 | $95 |
| GENZYME CORPORATION | 4 | $81 |
| Aimmune Therapeutics, Inc. | 3 | $65 |
Products named: TREMFYA, REZDIFFRA, RINVOQ, DUPIXENT, IBSRELA, CREON, Sucraid, VOQUEZNA.
Industry payments across MS — which companies pay providers there.
